BKR Reiterate Buy and $74 PT after results - EBITDA Exceeds Consensus by 9.4%; Robust IET Orders and 28% Increase in 2026 IET Order Guidance

BKR Reiterate Buy and $74 PT after results - EBITDA Exceeds Consensus by 9.4%; Robust IET Orders and 28% Increase in 2026 IET Order Guidance @ Stifel